Guidant's coronary dilation catheter cleared by FDA:
This article was originally published in Clinica
Executive Summary
Guidant has clearance from the FDA to market its ACS Tx2000 VP coronary dilation catheter in the US. The catheter, manufactured by Guidant's Vascular Intervention Group, is a 0.014 over-the-wire catheter with a rated burst pressure of 18 atmospheres. Guidant, based in Indianapolis, Indiana, estimates that nearly 750,000 people worldwide undergo a percutaneous procedure that requires a balloon angioplasty catheter.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.